A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection

Background: The direct-acting antiviral (DAA) agents are widely used to treat hepatitis C virus (HCV) genotype (GT) 1 infection, while it may cause severe liver damage. The objectives of the study were to evaluate the incidence of drug-induced liver injury (DILI), sustained virologic response at pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Hsuan-Yu, Chen, Chung-Yu, Liao, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458878/
https://www.ncbi.nlm.nih.gov/pubmed/34566631
http://dx.doi.org/10.3389/fphar.2021.640317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458878/
https://www.ncbi.nlm.nih.gov/pubmed/34566631
http://dx.doi.org/10.3389/fphar.2021.640317

Ejemplares similares